1. Home
  2. IDYA vs LCII Comparison

IDYA vs LCII Comparison

Compare IDYA & LCII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IDYA
  • LCII
  • Stock Information
  • Founded
  • IDYA 2015
  • LCII 1956
  • Country
  • IDYA United States
  • LCII United States
  • Employees
  • IDYA N/A
  • LCII N/A
  • Industry
  • IDYA Biotechnology: Pharmaceutical Preparations
  • LCII Auto Parts:O.E.M.
  • Sector
  • IDYA Health Care
  • LCII Consumer Discretionary
  • Exchange
  • IDYA Nasdaq
  • LCII Nasdaq
  • Market Cap
  • IDYA 2.3B
  • LCII 2.3B
  • IPO Year
  • IDYA 2019
  • LCII N/A
  • Fundamental
  • Price
  • IDYA $26.88
  • LCII $88.73
  • Analyst Decision
  • IDYA Buy
  • LCII Hold
  • Analyst Count
  • IDYA 15
  • LCII 3
  • Target Price
  • IDYA $47.92
  • LCII $89.33
  • AVG Volume (30 Days)
  • IDYA 1.2M
  • LCII 278.6K
  • Earning Date
  • IDYA 11-03-2025
  • LCII 11-06-2025
  • Dividend Yield
  • IDYA N/A
  • LCII 5.19%
  • EPS Growth
  • IDYA N/A
  • LCII 25.42
  • EPS
  • IDYA N/A
  • LCII 5.97
  • Revenue
  • IDYA $7,000,000.00
  • LCII $3,871,475,000.00
  • Revenue This Year
  • IDYA $63.41
  • LCII $7.80
  • Revenue Next Year
  • IDYA $305.49
  • LCII $4.31
  • P/E Ratio
  • IDYA N/A
  • LCII $14.83
  • Revenue Growth
  • IDYA N/A
  • LCII 1.36
  • 52 Week Low
  • IDYA $13.45
  • LCII $72.31
  • 52 Week High
  • IDYA $32.67
  • LCII $129.38
  • Technical
  • Relative Strength Index (RSI)
  • IDYA 59.69
  • LCII 28.56
  • Support Level
  • IDYA $26.77
  • LCII $91.75
  • Resistance Level
  • IDYA $28.41
  • LCII $95.31
  • Average True Range (ATR)
  • IDYA 0.92
  • LCII 2.18
  • MACD
  • IDYA 0.04
  • LCII -0.83
  • Stochastic Oscillator
  • IDYA 59.24
  • LCII 0.22

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

About LCII LCI Industries

LCI Industries Inc supplies domestically and internationally components for the original equipment manufacturers of recreational vehicles and adjacent industries including buses; and trailers used to haul boats, livestock, equipment, and other cargo. It has two reportable segments; the original equipment manufacturers segment and the aftermarket segment. The OEM Segment manufactures or distributes components for the OEMs of RVs and adjacent industries, including buses; trailers used to haul boats, livestock, equipment, and other cargo; trucks; pontoon boats; trains; manufactured homes; and modular housing. Its products are sold to manufacturers of RVs such as Thor Industries, Forest River, Winnebago, and other RV OEMs, and to manufacturers in adjacent industries.

Share on Social Networks: